Table 2 of
Micheal, Mol Vis 2014; 20:1471-1479. Table 2 of
Micheal, Mol Vis 2014; 20:1471-1479.
Table 2. Genotype frequencies in POAG, PACG, PEXG patients and controls.
| Genotypes | POAG n=268 (%) | Controls n=233 (%) | p (χ2) | PACG n=125 (%) | p (χ2) | PEXG n=120 (%) | p (χ2) |
|---|---|---|---|---|---|---|---|
| CDKN2B-AS1 rs4977756 | |||||||
| AA | 143 (53.3) | 135 (57.9) | 0.37 (1.95) | 73 (58.4) | 0.82 (0.39) | 65 (54.2) | 0.62 (0.93) |
| AG | 109 (40.7) | 81 (34.8) | 45 (36.0) | 43 (35.8) | |||
| GG | 16 (6.0) | 17 (7.3) | 7 (5.6) | 12 (10.0) | |||
| CDKN2B rs1063192 | |||||||
| TT | 134 (50.0) | 127 (54.5) | 0.51 (1.33) | 72 (57.6) | 0.76 (0.53) | 64 (53.3) | 0.67 (0.77) |
| CT | 116 (43.3) | 89 (38.2) | 46 (36.8) | 44 (36.7) | |||
| CC | 18 (6.7) | 17 (7.3) | 7 (5.6) | 12 (10.0) | |||
| ATOH7 rs1900004 | |||||||
| CC | 111 (41.4) | 110 (47.2) | 0.41 (1.76) | 68 (54.4) | 0.03 (6.54) | 51 (42.5) | 0.45 (1.57) |
| CT | 127 (47.4) | 98 (42.1) | 53 (42.4) | 51 (42.5) | |||
| TT | 30 (11.2) | 25 (10.7) | 4 (3.2) | 18 (15.0) | |||
| CAV1 rs4236601 | |||||||
| GG | 145 (54.1) | 150 (64.4) | 0.02 (7.16) | 76 (60.8) | 0.30 (2.40) | 75 (62.5) | 0.26 (2.62) |
| AG | 105 (39.2) | 76 (32.6) | 41 (32.8) | 37 (30.8) | |||
| AA | 18 (6.7) | 7 (3.0) | 8 (6.4) | 8 (6.7) | |||
| TMCO1 rs4656461 | |||||||
| AA | 219 (81.7) | 162 (69.5) | 0.005 (10.31) | 103 (82.4) | 0.02 (7.51) | 98 (81.7) | 0.03 (6.52) |
| AG | 47 (17.53) | 69 (29.6) | 22 (17.6) | 22 (18.3) | |||
| GG | 2 (0.75) | 2 (0.9) | 0 (0.0) | 0 (0.00) | |||
| SIX1 rs10483727 | |||||||
| CC | 65 (24.2) | 46 (19.7) | 0.39 (1.88) | 19 (15.2) | 0.32 (2.23) | 20 (16.7) | 0.68 (0.76) |
| CT | 128 (47.8) | 112 (48.1) | 70 (56.0) | 63 (52.5) | |||
| TT | 75 (28.0) | 75 (32.2) | 36 (28.8) | 37 (30.8) |